Atrophy and tau pathology are key biomarkers for classifying Alzheimer’s disease (AD), but their relationship isn’t clear. This study provided this information, helping further support AD diagnoses and treatments further. #alzresearch #medicalimaging https
114 followers
505 followers
RT @Rosaleena_M: 📢Does AD heterogeneity modulate the association between tau pathology & atrophy? Can AD heterogeneity be better modeled as…
3,107 followers
RT @Rosaleena_M: 📢Does AD heterogeneity modulate the association between tau pathology & atrophy? Can AD heterogeneity be better modeled as…
5 followers
RT @Rosaleena_M: 📢Does AD heterogeneity modulate the association between tau pathology & atrophy? Can AD heterogeneity be better modeled as…